Clinical Trials Directory

Trials / Completed

CompletedNCT00529295

Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
220 (actual)
Sponsor
China Medical University Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to estimate the safety and efficacy of titrated oral misoprostol compared with vaginal route for labor induction at term.

Detailed description

Oral misoprostol absorption is more rapid and possible more predictable, with a peak serum concentration following oral administration of 34 minutes and a half-life of 20-40 minutes. Peak serum concentration for vaginal administration is 60-80 minutes, this level being sustained for up to four hours. Although the direct local effect of vaginal administration on cervical ripening may be advantageous, the shorter half-life of oral delivery may be beneficial in the event of uterine hyperstimulation.In order to avoid uterine hyperstimulation, it appears reasonable to suggest that oral misoprostol should be administered in small, frequent doses, titrated against the uterine response.

Conditions

Interventions

TypeNameDescription
DRUGmisoprostolTitrated oral misoprostol: one tablet of 200 microgram was dissolved in water 200 ml, and 20 ml P.O. per one hour for 4 doses, then titrated against uterine response; Vaginal misoprostol: 25 microgram per vagina

Timeline

Start date
2005-06-01
Completion
2007-03-01
First posted
2007-09-14
Last updated
2007-09-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00529295. Inclusion in this directory is not an endorsement.